Sign in to view content

Evaluating Intravitreal ANX007, a Novel C1q Inhibitor, in the Treatment of GA Secondary to AMD: The ARCHER Study

David S. Boyer, MD

Video
Published 2021

Related

Episode 17: 5-year Results of DRCR.net Protocol S: PRP laser vs Ranibizumab for PDR with Dr. Jennifer Sun
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
E27- DRCR Protocol V Results- Anti-VEGF vs Focal Laser vs Observation for DME in Eyes with Very Good Vision- Dr. Jennifer Sun
Keyvan Koushan, MD, FRCSC
Member Podcasts
Combined Hamartoma of the Retina and Retinal Pigment Epithelium at Pediatric Age: Surgical vs Conservative Treatment: A Retrospective Multicenter Study
Sengul Ozdek, MD, FEBO, FASRS
On Demand Cases, Courses, and Papers
2021

Category: AMD-Non-Neovascular

See more